Benefits of contingent screening vs primary screening by cell-free DNA testing: think again

Ultrasound Obstet Gynecol. 2016 May;47(5):542-5. doi: 10.1002/uog.15758. Epub 2016 Mar 27.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cell-Free System
  • Chromosome Disorders / diagnosis*
  • DNA / blood*
  • Female
  • Humans
  • Nuchal Translucency Measurement / methods*
  • Pregnancy
  • Pregnancy Trimester, First
  • Pregnancy-Associated Plasma Protein-A / metabolism
  • Prenatal Diagnosis / methods*

Substances

  • DNA
  • Pregnancy-Associated Plasma Protein-A
  • PAPPA protein, human